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Most newly synthesized peroxisomal proteins are targeted to the organelle by Pex5p, the peroxisomal cycling receptor. Pex5p interacts with
these proteins in the cytosol, transports them to the peroxisomal docking/translocation machinery and promotes their translocation across the
organelle membrane. Finally, Pex5p is recycled back to the cytosol in order to catalyse additional rounds of transportation. Although several
properties of this protein sorting pathway have been recently uncovered, we are still far from comprehending many of its basic principles. Here,
we describe the mechanistic implications of two single-amino acid substitutions in Pex5p. The first mutation characterized, Cys11Ser, blocks the
recycling of Pex5p back into the cytosol at the step in which stage 2 Pex5p is converted into stage 3 Pex5p. The mutation Asn526Lys, previously
described in a child with neonatal adrenoleukodystrophy and shown to abolish the PTS1-binding capacity of Pex5p, results in a Pex5p protein
exhibiting import capacity. Protease assays suggest that the Asn526Lys mutation causes conformational alterations at the N-terminal half of Pex5p
mimicking the ones induced by binding of a PTS1-containing peptide to the normal peroxin. The implications of these findings on the mechanism
of protein translocation across the peroxisomal membrane are discussed.
© 2007 Elsevier B.V. All rights reserved.Keywords: Pex5p; Peroxisomes; Protein translocation; Peroxisomal matrix proteins1. Introduction
Peroxisomal matrix proteins are synthesized in cytosolic
ribosomes and post-translationally targeted to the peroxisome.
Specific targeting of these newly synthesized proteins to the
organelle is warranted by the existence of peroxisomal targeting
signals (PTSs) in their primary structure. There are two well-
defined PTSs: the so-called PTS1 is a tripeptide with the
sequence S–K–L (or similar) present at the extreme C-terminus
of most matrix proteins [1,2]; the PTS2 is a degenerateAbbreviations: PTS, peroxisomal targeting signal; PNS, postnuclear super-
natant; MOPS, 4-morpholinepropanesulfonic acid; DTT, dithiothreitol; ATPγS,
adenosine 5′- O- (thiotriphosphate); TPR, tetratricopeptide repeats
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doi:10.1016/j.bbamcr.2007.04.011nonapeptide found at the N-terminus of a few matrix proteins
[3–5]. In mammals, both classes of matrix proteins are targeted
to the peroxisome by Pex5p [6,7]. PTS1-containing proteins are
directly recognized (bound) by the C-terminal half of this
peroxin, a region comprising several TPR domains [8,9]; PTS2-
containing proteins are recognized indirectly by the large
isoform of Pex5p, through the adaptor protein Pex7p [10–12].
After this recognition event, cargo-loaded Pex5p interacts
with the so-called importomer, a large, but probably transient,
protein complex present at the peroxisomal membrane [13–15].
This importomer comprises many different peroxins which can
be divided into two functional groups: Pex2p, Pex10p, Pex12p,
Pex13p, Pex14p and, in yeast, also Pex8p and Pex17p, are
probably involved in the docking of the receptor–cargo protein
complexes at the peroxisomal membrane and in the transloca-
tion of the cargo proteins across this membrane system; Pex1p,
Pex6p and Pex26p (in mammals) or Pex15p (in yeast), are in
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into the cytosol, so that it can engage in additional rounds of
protein transportation (reviewed in [16,17]).
Despite our knowledge on many of the properties of this
protein sorting pathway, we are still far from understanding its
basic principles. For instance, although the peroxisomal
membrane lacks large pores and, accordingly, is impermeable
to many small metabolites (reviewed in [18,19]), many
peroxisomal proteins are translocated across the peroxisomal
membrane in their folded, even oligomeric state [20–22]. The
mechanism of this process remains completely unknown.
A classical approach that has been used for many years in the
characterization of the mechanisms of protein translocation
across biological membranes relies on the use of in vitro import
systems. A few years ago we started to apply this strategy to
study the Pex5p-mediated protein import process [23]. This in
vitro system consists in incubating 35S-labeled Pex5p with
organelles from rat liver and it explores the fact that soluble
(cytosolic) Pex5p is extremely sensitive to proteolysis due to the
natively unfolded nature of a large portion of its polypeptide
chain [24,25], a property that changes completely when Pex5p
is inserted into the peroxisomal membrane. This strategy has
been successfully applied and adapted to other organisms by
other laboratories [26,27].
During recent years, the data obtained using this approach
led to the conclusion that Pex5p is inserted into the peroxisomal
membrane in a Pex13p-, Pex14p- and cargo-dependent process
[23,28], an event that, unexpectedly, does not require ATP
hydrolysis [26,27,29]. ATP is, in fact, needed in the Pex5p-
mediated protein transport process but only during the export
step [29], when the receptor is recycled back into the cytosol by
the action of Pex1p and Pex6p [26,27]. It was also shown that
the first 17 amino acid residues of Pex5p are absolutely required
for this export step [25].
Interestingly, after insertion into the peroxisomal membrane
of mammals two different membrane-bound populations of
Pex5p can be detected [23,26]: the so-called stage 2 Pex5p
exposes the majority of its mass into the matrix of the organelle
and about 2 kDa of its N-terminus into the cytosol, as assessed
by protease-protection experiments using proteinase K; stage 3
Pex5p is completely resistant to this protease and becomes a
particularly prominent species under ATP-limiting conditions
[23]. Furthermore, several independent observations established
that stage 2 is the precursor of stage 3 ([23,28,29]; see also
Discussion). These observations together with the finding that
these two Pex5p populations are still associated with Pex14p
[23], led us to propose that cargo proteins are translocated
across the peroxisomal membrane by Pex5p itself in a process
energetically driven by simple protein–protein interactions
involving Pex5p on one side and the subunits of the importomer
on the other [30,31]. This perspective is, thus, incompatible
with the so-called extended version of the cycling receptor
model, which predicts that cargo-loaded Pex5p is completely
translocated across the peroxisomal membrane during the
protein transport process (reviewed in [32]).
In order to gather more data on the mechanism of the Pex5p-
mediated import pathway we have started to address the role ofspecific domains/amino acid residues in the function of this
peroxin. Here, we describe the functional implications of
mutating a cysteine residue at position 11 of Pex5p. In addition,
the unexpected properties of a Pex5p mutant version unable to
bind PTS1-containing proteins are also presented.
2. Materials and methods
2.1. In vitro import reactions
Rat liver postnuclear supernatants (PNS) were prepared in SEM buffer
(0.25 M sucrose, 20 mM MOPS-KOH, pH 7.4, 1 mM EDTA–NaOH, pH 7.4)
supplemented with 2 μg/ml N-(trans-epoxysuccinyl)-L-leucine 4-guanidinobu-
tylamide, as described before [23]. In vitro import reactions (100 μl) contained
300 μg of PNS protein and 0.3–1.0 μl of the relevant reticulocyte lysates in
import buffer (0.25M sucrose, 50 mMKCl, 20 mMMOPS-KOH, pH 7.4, 3 mM
MgCl2, 0.2% (w/v) lipid-free bovine serum albumin, 20 μM methionine, and
2 μg/ml N-(trans-epoxysuccinyl)-L-leucine 4-guanidinobutylamide). Unless
otherwise specified, import reactions were incubated for 20 min at 37 °C. ATP
and ATPγS were used at 10 mM final concentrations. In the experiment shown
in Fig. 1B an ATP-regenerating system (10 mM creatine phosphate and creatine
phosphokinase 5 units/ml, final concentrations) was also included. The cargo-
dependence experiments were performed as described previously but using a
His-tagged recombinant protein comprising amino acid residues 314–639 of
Pex5p (TPRs-Pex5p; [24]) instead of the GST-fusion protein described before
(see [33]). The concentration of TPRs-Pex5p in the import reactions was
0.17 μM. To reverse the inhibitory action of TPRs-Pex5p a PTS1-containing
peptide (see below) was included in the import reactions at 8 μM final
concentration. Proteinase K treatment of import reactions and processing of
protein samples for SDS-PAGE and autoradiography was done exactly as
described [23].
2.2. Construction of PEX5 cDNAs
A cDNA encoding the small isoform of Pex5p was obtained using a ligation-
PCR strategy and pGEM4-Pex5 [23] as a template. The upstream and
downstream flanking sequences of exon 8 of Pex5p were amplified with primers
CCGGTCGACATGGCAATGCGGGAGCTGGTGGA (1F) and GGCATCT-
GATGTACCCTCAGAATTAGCCAATTTGGGGTCATCC (2R), and
TTGGCTAATTCTGAGGGTACATCAGATGCCTGGGTTGACCAGT (3F)
and GCGGTCGACCTGTCACTGGGGCAGGCCAAACATAG (4R). The
resulting PCR products were mixed and amplified with primers 1F and 4R and
cloned into pGEM®-T Easy vector. The recombinant plasmid was digested with
SalI and the insert was cloned into the SalI site of pGEM-4 (Promega),
originating pGEM4-Pex5S.
Plasmids encoding Pex5L(C11S)p, Pex5L(N526K)p and Pex5S(N489K)p
were obtainedwith the QuickChange® Site-DirectedMutagenesis Kit (Stratagene)
using the primer pairs 5′-GGAGCTGGTGGAGGCCGAAAGCGG-
GGGTGCCAACCCGC-3′ and 5′-GCGGGTTGGCACCCCCGCTTTCGGC-
CTCCACCAGCTCC-3′ for the C11S mutation and 5′-GACTATTTGCTGTG-
GAAGAAGCTAGGCGCCACCCTGGC-3′ and 5′-GCCAGGGTGGCGCC-
TAGCTTCTTCCACAGCAAATAGTC-3′ for the N526/489K mutation. The
templates used in the PCR step of the mutagenesis protocol were: pQE-Pex5, a
plasmid encoding the large isoform of human Pex5p [25] to obtain pQE-Pex5L
(C11S) and pQE-Pex5L(N526K); pQE-TPRs-Pex5 (a pQE-derivative encoding
amino acid residues 314–639 of Pex5Lp [24]) to obtain pQE-TPRs-Pex5(N526K);
and pGEM4-Pex5S to obtain pGEM4-Pex5S(N489K).
2.3. Synthesis of 35S-labeled Pex5p proteins
cDNAs encoding Pex5L(C11S)p and Pex5L(N526K)p preceded by the T7
RNA polymerase promoter were produced by expression PCR [34] using as
templates the plasmids described above. In the first PCR, the plasmids were
amplified using the forward primer 5′-GGGAGAGCCACCATGG-
CAATGCGGGAGCTG-3′ and the reverse primer 5′-GCGGTCGACT-
CACTGGGGCAGGCCAAACAT-3′. In the second PCR, this reverse primer
Fig. 1. The C11S mutation blocks export of Pex5p by blocking the stage 2 to
stage 3 transition. (A) 35S-labeled Pex5Lp and Pex5L(C11S)p were incubated
with a PNS fraction from rat liver in the absence of exogenous nucleotides (−),
in the presence of 10 mM ATP (ATP) or 10 mM ATPγS (ATPγS), as indicated.
After 20 min at 37 °C, the import reactions were treated with proteinase K, the
organelles isolated by centrifugation and analysed by SDS-PAGE/autoradio-
graphy. In order to verify that insertion of Pex5L(C11S)p into the peroxisomal
membrane is cargo-dependent, three additional import reactions supplemented
with 10 mM ATP were also performed. The first received 5 μl of SEM buffer
alone (lane “0”); the second was supplemented with 5 μl of SEM containing
recombinant TPRs-Pex5p (lane “TPR”; 0.17 μM final concentration) to
sequester PTS1-containing proteins present in the import reaction. The third
(lane “TPRs+SKL”) contained in addition to this recombinant protein a PTS1-
containing peptide (see Materials and methods) to reverse the inhibitory action
of TPRs-Pex5p. I — 10% of the 35S-labeled proteins used in each import
reaction. The asterisk marks a truncated Pex5Lp protein occasionally present in
the reticulocyte lysates used to synthesize Pex5p. This fragment most likely
derives from translation initiation at an internal methionine because it becomes
particularly enriched in import reactions performed in the presence of ATP (it
lacks the domain necessary for the export step) and its insertion into the
peroxisomal membrane is cargo-dependent (compare lanes “TPR” and “TPR+
SKL”). (B) Import/Export kinetics of Pex5L(C11S)p. Mixtures of reticulocyte
lysates containing Pex5L(C11S)p and ΔN110-Pex5Lp (upper panel) or Pex5Lp
and ΔN110-Pex5Lp (lower panel) were subjected to import reactions in the
presence of ATP for the indicated periods of time. After proteinase K treatment,
the organelles were sedimented and analysed by SDS-PAGE/autoradiography. Ia
and Ib, 10% of the 35S-labeled proteins used in each import reaction. The
graphic shows ratios of protease protected species normalized for the inputs as a
function of time. Squares — ratio Pex5L(C11S)p/ΔN110-Pex5Lp; triangles—
ratio Pex5Lp/ΔN110-Pex5Lp;
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TATAGGGAGAGCCACCATG-3′. 35S-labeled proteins were synthesized using
the TNT® T7 Quick Coupled Transcription/Translation kit (Promega) in the
presence of RedivueTM L-[35S]methionine (specific activityN1000 Ci/ mmol)
following the manufacturer's instructions. 35S-labeled Pex5Lp, Pex5Sp, Pex5S
(N489K)p, ΔN110-Pex5Lp and ΔC1-Pex5Lp were synthesized using the
strategies described before [28,33].
2.4. Protease assays
Recombinant proteins (5 μg in 50 μl of 50 mM Tris–HCl, pH 7.5, 150 mM
NaCl, 1 mM EDTA, and 1 mM DTT) were incubated at 37 °C for 10 min with
10 μM of a PTS1-containing peptide (CRYHLKPLQSKL) or a control peptide
(CRYHLKPLQLKS; see [33]), as indicated. The samples were placed on ice and
treated for 15 min with proteinase K (1 μg/ml) or trypsin (8 μg/ml). After
inactivation of the protease with phenylmethylsulfonyl fluoride (0.5 mg/ml), the
proteins were precipitated with trichloroacetic acid (10% (w/v)), washed with
acetone, and analysed by SDS-PAGE.
2.5. Miscellaneous
The purification of His-tagged Pex5p recombinant proteins was described
before [24]. Densitometric analysis of X-ray films was performed using the UN-
SCAN-IT automated digitizing system. Edman degradation of proteolytic
fragments was performed by HHMI/Keck Biotechnology Resource Laboratory
(New Haven, CT).3. Results
3.1. Mutation of cysteine 11 in Pex5Lp leads to a block in its
export pathway by blocking the stage 2 to stage 3 transition
In a previous work we have shown that the first 17 amino
acid residues of Pex5p are essential for the ATP-dependent
export step of peroxisomal Pex5p back into the cytosol [28].
This domain of Pex5p comprises a cysteine-containing motive
that is conserved in all Pex5p sequences presently available and
also in the functionally related peroxins, Pex18p, Pex20p and
Pex21p from lower eukaryotes [35]. Given the ease with which
(reduced) cysteine residues can be modified in vitro, we made a
set of preliminary in vitro import experiments aiming at
monitoring the export capacities of Pex5Lp and ΔC1-Pex5Lp
(a truncated version of Pex5Lp containing only its first 324
aminoacid residues; see [28,33]) pretreated with iodoacetamide.
While the peroxisomal import rates of these two alkylated forms
of Pex5Lp were normal (ΔC1Pex5Lp) or almost normal
(Pex5Lp), the export step of both proteins was found to be
severely affected (data not shown). Since ΔC1Pex5Lp contains
only one cysteine residue, the one present in the above-
mentioned motive, these observations prompted us to mutate
Cys11 of Pex5Lp to the structurally related amino acid serine
and to use this mutant protein [Pex5L(C11S)p] in in vitro import
experiments. As shown in Fig. 1A, incubation of 35S-labeled
Pex5L(C11S)p with a PNS fraction in the presence of ATP
results in a proteinase K-resistant species that is 2 kDa shorter
than the complete protein. This species corresponds to stage 2
Pex5p (see Introduction). The same result was obtained with a
C-terminally truncated version comprising the first 324 amino
acid residues of Pex5L(C11S)p (data not shown). Insertion of
Pex5L(C11S)p into the peroxisomal membrane is cargo protein-
Fig. 2. Pex5L(N526K)p/Pex5S(N489K) are imported into peroxisomes in a
cargo-independent process. (A) Standard import reactions in the absence of
exogenous nucleotides (lanes “−”), in the presence of 10 mMATP (lanes “ATP”)
or 10 mM ATPγS (lanes “ATPγS”) were performed with 35S-labeled Pex5Lp,
Pex5L(N526K)p, Pex5Sp and Pex5S(N489K)p. (B) Insertion of Pex5L(N526K)
p or Pex5S(N489K)p into the peroxisomal membrane is not inhibited when
PTS1-containing proteins are sequestered from the import medium by addition
of large amounts of TPRs-Pex5p. These experiments were performed as
described in the legend of Fig. 1A.
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indicating that the C11S mutation does not interfere with the
first steps of the Pex5p-mediated import pathway, as expected.
However, and in agreement with the results of the iodoaceta-
mide experiments, the fraction of the input protein that can be
detected at stage 2 in the presence of ATP is higher for the
Pex5L(C11S)p mutant protein than for the normal peroxin (23%
versus 7%, respectively). As shown below, this phenomenon
derives from the fact that the ATP-dependent export step of
Pex5L(C11S)p back into the soluble fraction is blocked.
Interestingly, in contrast to the results obtained with the normal
Pex5Lp protein, no fully protease-protected species (corre-
sponding to stage 3 Pex5p) can be observed with the Pex5L
(C11S)p mutant protein, even when ATPγS is used in these
experiments. This ATP analogue blocks the export step leading
to an accumulation of Pex5p at the peroxisomal membrane at
stage 3 [23].
In order to quantify the degree of inhibition of the export step
caused by the C11S mutation, we compared the kinetics of
appearance of protease-protected Pex5L(C11S)p to the one
obtained with ΔN110-Pex5Lp. These experiments were
performed in the presence of ATP at 37 °C, conditions in
which normal Pex5p continuously enters and exits the
peroxisomal membrane displaying a half-life at the peroxisomal
membrane of less than 2.5 min [28]. As shown in Fig. 1B,
Pex5L(C11S)p displays the kinetic behaviour of ΔN110-
Pex5Lp. This is particularly evident when the ratios of stage 2
Pex5L(C11S)p to protease protected ΔN110-Pex5Lp are
plotted as a function of time: a straight line with a slope close
to 0 is obtained, implying that the import kinetics of these two
Pex5p versions are similar. In contrast the Pex5Lp/ΔN110-
Pex5Lp ratio decreases over time due to the fact that Pex5Lp
(but not ΔN110-Pex5Lp) is efficiently exported from the
peroxisomal membrane into the soluble (cytosolic) fraction, as
described before [28]. Taken together these data indicate that the
C11S mutation blocks the ATP-dependent export step of Pex5p
from the peroxisomal membrane by inhibiting the stage 2 to
stage 3 transition.
3.2. Pex5L(N526K)p, a mutant protein unable to interact with
PTS1-containing proteins, is a substrate for the peroxisomal
import and export machineries
Mutations in the gene encoding Pex5p define complementa-
tion group 2 of the peroxisome biogenesis disorders [8]. One of
the patients belonging to this group was reported to produce
normal amounts of a mutant Pex5p possessing a lysine at
position 526 instead of an asparagine. Cells of this patient have
an impaired PTS1-import pathway [8] and subsequent studies
have shown that the N526K mutation blocks the binding of
PTS1-containing cargo proteins to the C-terminal half of Pex5p
[9]. We produced this mutant protein [Pex5L(N526K)p] and
tested its functionality in our in vitro import system. Since in
this system insertion of Pex5p into the peroxisomal membrane
is a PTS1-dependent process no protease-protected species
derived from Pex5L(N526K)p should be detected. Strikingly,
the opposite result was obtained. As shown in Fig. 2A, importexperiments performed in the absence of exogenous nucleo-
tides, in the presence of ATP or ATPγS result in ratios of stage 2
to stage 3 Pex5L(N526K)p indistinguishable from the ones
obtained for Pex5Lp indicating that once at the importomer, this
mutant version of Pex5p displays the mechanistic properties of
the normal Pex5p version. The only difference between the two
proteins resides in the fraction of the input proteins entering this
pathway. Indeed, 2–3 fold more Pex5L(N526K)p than Pex5Lp
has to be added to these reactions so that similar amounts of
protease protected species are obtained.
Considering that the 35S-labeled proteins used in these
experiments correspond to the large isoform of Pex5p, a protein
that is also in charge of transporting PTS2-containing proteins
into the peroxisome [10–12], one possibility to explain these
results would be to assume that Pex5L(N526K)p is active in this
assay because it interacts with Pex7p.PTS2-containing cargo
protein complexes. Although unlikely (see [33]), we repeated
these experiments using the small isoform of Pex5p (Pex5Sp).
Due to alternative splicing of the PEX5 transcript, this version
of Pex5p lacks the Pex7p-binding site and is unable to promote
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2A, Pex5S(N489K)p (residue 489 of Pex5Sp corresponds to
residue 526 of Pex5Lp) is also a substrate for the peroxisomal
importomer. This possibility excluded, we finally raised the
hypothesis that Pex5L(N526K)p (or Pex5S(N489K)p) could
still possess some residual PTS1-binding activity. If this were
the case, then addition of a vast excess of the recombinant
PTS1-binding domain of Pex5p to the import reactions to
sequester PTS1-containing proteins should block the insertion
of these proteins into the peroxisomal membrane. As shown in
Fig. 2B, whereas the amounts of protease-protected Pex5Lp or
Pex5Sp are highly decreased under these conditions, as
described before [33], no inhibition can be observed for the
two versions possessing the asparagine to lysine mutation. Weconclude that these mutant versions of Pex5p are inserted into
the peroxisomal membrane in a cargo-independent process.
3.3. The N526K mutation causes conformational alterations in
regions preceding the C-terminal half of Pex5p that mimic the
ones induced by binding of a PTS1-containing peptide to the
normal peroxin
Previously, we proposed the existence of an auto-regulatory
mechanism in Pex5p. According to this model, the peroxisomal
targeting domain present at the N-terminal half of Pex5p is a
target of negative regulation exerted by its C-terminal cargo-
binding domain; binding of a PTS1-containing protein to Pex5p
releases this inhibition [33]. Obviously, the observations
described in the previous section challenge this idea. However,
it is also possible that the effects of the asparagine to lysine
mutation on the structure/function of Pex5p go beyond the
simple disruption of its PTS1-binding capacity. For instance,
this mutation could also interfere with the cross-talk between
the N- and C-terminal halves of Pex5p resulting in a
constitutively active peroxisomal targeting domain.
Presently the number of biochemical strategies that can be
used to address the interdomain cross-talk of Pex5p is quite
limited. In fact only two indirect methodologies have been used
for this purpose. The first consists in detecting differences in the
binding affinities of the N-terminal half of Pex5p for other
peroxins in the presence or absence of cargo proteins. Although
effects of this type have been shown for Pichia pastoris Pex5p
and Pex14p [36], mammalian Pex5p binds Pex14p with
apparently similar affinities both in the presence and absence
of PTS1-containing peptide/proteins ([37], and unpublishedFig. 3. The N526K mutation causes conformational alterations in regions
preceding the C-terminal half of Pex5p that mimic the ones induced by binding
of a PTS1-containing peptide to the normal peroxin. (A) Recombinant Pex5Lp
(lanes 2, 5, 6) and Pex5L(N526K)p (lanes 1, 3, 4) were incubated with a PTS1-
containing peptide (lanes 4 and 6) or a control peptide (lanes 3 and 5; see
Materials and methods for details) and subjected to partial proteolysis using
proteinase K (lanes 3–6). After inactivation of the protease, the samples were
subjected to TCA precipitation and subjected to SDS-PAGE. The N-terminal
sequences of polypeptides indicated by letters “a” and “b”were described before
[25]. Band “c” represents a fragment starting at amino acid residue 308 of
Pex5Lp. M, molecular mass standards (from top to bottom): 97, 66.2, 45.0, 31.0,
21.5 and 14.4 kDa. (B) Recombinant proteins comprising amino acid residues
314–639 of the normal (lanes 1–3) or the mutant N526K (lanes 4–6) versions
were incubated with the PTS1-containing peptide (lanes 2 and 5) or a control
peptide (lanes 3 and 6; see Materials and methods) and subjected to partial
proteolysis with trypsin (lanes 2, 3, 5, 6). A coomassie blue-stained gel is shown.
Letters a–f indicate fragments that were subjected to Edman degradation. Note
that a small amount of both recombinant proteins becomes cleaved, during the
production and purification steps (protein fragments of 20 and 18 kDa). M,
molecular mass markers (from top to bottom: 45, 31, 20 and 14.4 kDa). A
schematic representation of this region of Pex5p as well as of the major tryptic
fragments (fragments a–f) obtained in the presence of the PTS1-containing
peptide (“SKL”) or a control peptide (“LKS”) is also shown. The N-terminal
sequences of the fragments obtained with TPRs-Pex5p were determined by
Edman degradation and are shown within the boxes representing the obtained
fragments. The C-termini were estimated from the apparent sizes of the
corresponding fragments on this gel. The seven TPR motives are indicated in
grey. The black box represents the His-tag present in these proteins.
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protein pair in mammals. Pex13p binds stronger to free Pex5p
than to the cargo-loaded form [37]. Unfortunately, we were
unable to produce human Pex13p in a soluble state refraining us
of using this strategy.
The second approach to address this issue consists in probing
PTS1-induced conformational alterations in Pex5p by partial
proteolysis with proteinase K. Using this strategy, it was shown
that the conformation/environment of a region of Pex5Lp that
precedes its first TPR domain by 20–30 amino acid residues is
altered when Pex5Lp is loaded with a PTS1-containing peptide/
protein [25]. We tested recombinant Pex5L(N526K)p in this
assay. As shown in Fig. 3A, while the proteolytic patterns
obtained for Pex5Lp in the presence and in the absence of a
PTS1-containing peptide are clearly different, treatment of
Pex5L(N526K)p with the protease under both conditions results
in a single proteolytic pattern. Remarkably, the pattern obtained
for Pex5L(N526K)p corresponds to the one obtained with
Pex5Lp in the presence of the PTS1-peptide. This observation
suggests that the conformation/environment of the region that
precedes the TPR domains of Pex5p is similar in both Pex5L
(N526K)p and cargo-loaded Pex5Lp. Furthermore, since all the
major Pex5p fragments detected in these experiments contain
the C-terminal half of the peroxin (see [25] and legend to Fig.
3), these results also suggest that the conformation of the TPR
domains of Pex5p is not dramatically changed by the N526K
mutation. If this was the case then much smaller protein
fragments would be expected as observed, for instance, when a
Pex5Lp protein lacking the last 41 amino acid residues is used
in this assay (data not shown).
One possibility to explain the properties of Pex5L(N526K)p
would be to assume that this mutation causes conformational
alterations in the C-terminal half of Pex5p mimicking the ones
induced by the binding of a PTS1-containing cargo protein [38].
Again, we used a partial proteolysis approach to address this
issue. Two recombinant proteins comprising amino acid
residues 314–639 of the normal and mutated Pex5Lp versions
(TPRs-Pex5p and TPRs-Pex5(N526K)p, respectively) were
subjected to partial proteolysis using trypsin. As shown in Fig.
3B, this assay reveals the existence of PTS1-induced con-
formational alterations in the C-terminal half of Pex5p. Indeed,
TPRs-Pex5p is more susceptible to the protease when the
digestion is performed in the absence of the PTS1 peptide. This
result is in agreement with the recently described structures of
this Pex5p domain in its free and cargo-bound states, which
reveal that the former is much more flexible and less compact
than the latter [38]. Interestingly, the proteolytic pattern of
TPRs-Pex5(N526K)p corresponds to the one obtained with
TPRs-Pex5p in the absence of the PTS1 peptide. Apparently,
the N526K mutation does not induce compactization of the C-
terminal half of Pex5p.
4. Discussion
In this work we describe the mechanistic implications of two
missense mutations in Pex5p. One of these mutations, the
substitution of a cysteine by a serine at position 11 of Pex5Lp,blocks the export step of peroxisomal Pex5Lp back into the
cytosol. This finding is in complete agreement with our
previous observations showing that a Pex5p version lacking
the first 17 amino residues of this peroxin is not exported from
the peroxisomal membrane. Those and other observations (see
discussion in ref. [28]), together with the fact that cysteine 11 is
one of the few residues conserved in this short region of Pex5p
and Pex5p-like proteins [35,39] led us to propose that this
domain of Pex5p comprises the binding site for the machinery
catalysing the recycling of the PTS1-receptor back into the
cytosol. Interestingly, recent steady-state data led to the
discovery that the corresponding residue of P. pastoris Pex20p
(a Pex5p-like peroxin) is also necessary for the export step [40].
Besides refining our previous observations, the properties of
Pex5L(C11S)p should also clarify some doubts raised recently
regarding the relationship between stage 2 and stage 3 Pex5p.
Several findings from our laboratory suggest that stage 2 is the
precursor of stage 3 Pex5p. These include: (1) the fact that stage
2 can be chased into stage 3 Pex5p in in vitro pulse-chase
experiments performed in the presence of ATPγS; (2) the
observation that the ATP-dependent export kinetics of stage 3
Pex5p is faster than the observed for stage 2 Pex5p; (3) the
observation that only stage 2 Pex5p can be detected in an
incomplete in vitro import system lacking an active export
machinery and (4) that the transition of stage 2 into stage 3
Pex5p is blocked by low temperatures, conditions which also
inhibit the export step of Pex5p [23,28,29]. However, it was
recently argued that since stage 3 Pex5p is mainly detected
under ATP-limiting conditions, which allow Pex5p import into
peroxisomes but not its export , then it should precede stage 2
Pex5p [41]. Naturally, such interpretation would leave room for
the extended receptor cycling model because the protein
translocation step would be linked to a Pex5p population that
is not accessible to exogenously added proteases, presumably
the result of a peroxisomal matrix localization. The observation
that no stage 3 Pex5p can be detected with Pex5L(C11S)p even
when the import experiments are performed in the presence of
ATPγS further invalidates this new interpretation. In fact, these
results strongly suggest that peroxisomal Pex5p has to reach
stage 3 in order to be exported from the peroxisomal membrane.
The properties displayed by Pex5L(C11S)p also raise new
hypotheses regarding the mechanism of the export step.
According to recent data obtained in yeast, export of Pex5p
from the peroxisomal membrane may be linked to a
ubiquitylation event [27,42,43] although ubiquitylation of
Pex5p has also been interpreted by other authors as reflecting
the existence of quality-control mechanisms at the peroxisomal
importomer [44,45]. Despite several attempts we have been
unable to detect a similar modification in our in vitro import
experiments not even with the Pex5L(C11S)p mutant version
(unpublished observations). Thus, if ubiquitylation is also
linked to the export step of mammalian Pex5p back into the
cytosol, then it may occur only after stage 2. Alternatively,
cysteine 11 itself is ubiquitylated. These observations should
encourage further experiments with yeasts (organisms in which
Pex5p ubiquitylation is easily observed) aiming at clarifying
this matter.
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PTS1-binding activity of Pex5p [8,9]. One of the aims in
producing this mutant version of Pex5p was in fact to obtain a
protein that could be used as a control in our in vitro system.
Strikingly, Pex5L(N526K)p proved to be quite efficient in these
assays. This observation together with the results of the protease
assays strongly suggests that the N526K mutation disrupts the
interdomain cross-talk in Pex5p. This in turn raises the
interesting possibility that the region of the C-terminal half of
Pex5p that controls the peroxisomal targeting domain of Pex5p
overlaps with the PTS1-binding site. We are convinced that
Pex5L(N526K)p will be a helpful tool in any future attempt to
clarify this issue.
Regardless of the mechanistic reasons behind the behaviour
of Pex5L(N526K)p the results described here have two
additional implications. First, they clearly show that the
triggering mechanism to activate the peroxisomal docking/
translocation machinery emerges basically from Pex5p and not
from some interaction involving Pex5p-bound cargo proteins on
one side and the membrane peroxins on the other. This provides
one additional argument to support the notion that Pex5p itself
is the protein translocase. Second, the properties of Pex5L
(N526K)p also demonstrate that an hypothetical cargo-induced
oligomerization of Pex5p at or in the peroxisomal membrane,
the central concept of the so-called pre-implex model [46] and
an idea that could be easily included also in the transient pore
model [32], is not a sine qua non condition for insertion of
Pex5p into the organelle membrane. This is a property that
should be integrated in any future model aiming at describing
the Pex5p-mediated protein import process.
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